Latest News

Are periodontitis, stroke, and Alzheimer’s disease linked?


 

Prescribe oral hygiene

Regarding recommendations that neurologists should follow during consultations in light of the link between these diseases and periodontitis, Dr. Frank said, “Regardless of how old our patients are, I believe it’s important to emphasize the importance of practicing good oral and dental hygiene. It’s a good strategy to put this in writing in medical reports, alongside the usual recommendations about healthy lifestyle habits and monitoring for diseases like high blood pressure, diabetes, or dyslipidemia. These, among other factors like smoking, a sedentary lifestyle, alcoholism, and other drug addictions, are vascular risk factors and are therefore risk factors for stroke and dementia.”

According to Dr. Frank, the public is largely unaware of the relationship between periodontitis and incident neurologic diseases. “We still have a long way to go before we can say that the public is aware of this potential link. And not just the public, either. I believe we must stress among our colleagues and among health care professionals in general the importance of promoting dental health to improve people’s overall health.”

In this regard, Dr. Leira emphasized the authors’ intention to make this report available not only to oral health and neurologic health care professionals but also to primary care physicians and nurses so that patients with cerebrovascular disease or Alzheimer’s disease and their caregivers can develop a greater awareness and thereby improve prevention.

“This study will also provide the scientific basis to support the SEPA-SEN working group as they implement their future activities and projects,” Dr. Leira concluded.

Dr. Leira and Dr. Frank have disclosed no relevant financial relationships.

This article was translated from the Medscape Spanish Edition. A version of this article appeared on Medscape.com.

Pages

Recommended Reading

Hearing aids are a ‘powerful’ tool for reducing dementia risk
Journal of Clinical Outcomes Management
FDA approves first drug to treat Alzheimer’s agitation
Journal of Clinical Outcomes Management
Deep sleep may mitigate the impact of Alzheimer’s pathology
Journal of Clinical Outcomes Management
Internet use a modifiable dementia risk factor in older adults?
Journal of Clinical Outcomes Management
CMS to cover Alzheimer’s drugs after traditional FDA okay
Journal of Clinical Outcomes Management
Flavanol supplement improves memory in adults with poor diets
Journal of Clinical Outcomes Management
Game-changing Alzheimer’s research: The latest on biomarkers
Journal of Clinical Outcomes Management
Blood biomarker may help predict who will develop Alzheimer’s
Journal of Clinical Outcomes Management
Muscle fat: A new risk factor for cognitive decline?
Journal of Clinical Outcomes Management
Daily multivitamins boost memory in older adults: A randomized trial
Journal of Clinical Outcomes Management